Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus Skin Distribution and PK in Atopic Dermatitis
NCT00534508Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Dec 2000
- Primary completion
- Jul 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Tacrolimus Ointment 0.1% Iwaki in atopic dermatitis (AD), sponsored by Astellas Pharma. Started Dec 2000; status: completed.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00534508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00534508.